PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Clinical trial NCT06673017 · RECRUITING

Trial details

NCT number: NCT06673017
Sponsor: PanTher Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Borderline Resectable Pancreatic Adenocarcinoma Locally Advanced Pancreatic Adenocarcinoma Pancreatic Cancer

Start date: 2025-04-14
Primary completion: 2026-09-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.